Alaunos Therapeutics (TCRT) News Today → How to camouflage a factory of 53,000 workers (From Stansberry Research) (Ad) Free TCRT Stock Alerts $1.18 -0.02 (-1.67%) (As of 04/24/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineRevolution Medicines: An Expensive Shot At A Massive Market Opportunityseekingalpha.com - April 12 at 6:37 AMTCRT Stock Earnings: Alaunos Therapeutics Misses EPS for Q4 2023investorplace.com - April 8 at 2:02 PMBiora Therapeutics announces $6M registered direct offering and concurrent private placementmsn.com - April 1 at 2:08 PMAlaunos Therapeutics (NASDAQ:TCRT) Trading 9% Higher marketbeat.com - February 2 at 1:15 PMmarketbeat.com - February 1 at 6:08 AMAlaunos Therapeutics Announces 1-for-15 Reverse Stock Splitmsn.com - January 31 at 4:00 PMWerewolf Therapeutics Inc (HOWL)investing.com - January 31 at 11:00 AMAlaunos Therapeutics Stock (NASDAQ:TCRT) Dividends: History, Yield and Datesbenzinga.com - December 28 at 9:52 AMRecap: Alaunos Therapeutics Q3 Earningsbenzinga.com - November 14 at 12:52 PMWhy Is Alaunos Therapeutics (TCRT) Stock Up 14% Today?investorplace.com - November 14 at 10:01 AMAlaunos Therapeutics Announces Third Quarter 2023 Financial Results, Phase 1 Clinical Data and Continued Exploration of Strategic Alternativesfinance.yahoo.com - November 14 at 7:52 AMAlaunos Therapeutics Inc TCRTmorningstar.com - November 1 at 1:58 PMWhy Is Alaunos Therapeutics Sinking Today?msn.com - August 15 at 4:49 PMAlaunos Therapeutics Announces Second Quarter 2023 Financial Results, Interim Clinical Data and Exploration of Strategic Alternativesfinance.yahoo.com - August 14 at 6:24 PMmarketbeat.com - August 14 at 4:06 PMAlaunos Therapeutics Announces Presentation at the 2nd Hawaii Global Summit on Thoracic Malignanciesfinance.yahoo.com - June 29 at 9:05 AMAlaunos Therapeutics Stock (NASDAQ:TCRT), Insider Trading Activitybenzinga.com - June 9 at 5:28 PMAlaunos slips 17% on Phase 1/2 data for cancer cell therapymsn.com - May 26 at 4:00 PMAlaunos Therapeutics to Present Early Data from TCR-T Library Phase 1/2 Trial at 2023 American Society of Clinical Oncology Annual Meetingfinance.yahoo.com - May 25 at 8:30 PMOne Alaunos Therapeutics Insider Raised Stake By 117% In Previous Yearuk.news.yahoo.com - May 17 at 4:10 AMAlaunos Therapeutics upgraded to buy at Wainwright on multiple catalystsseekingalpha.com - May 15 at 3:56 PMAlaunos Therapeutics, Inc. (NASDAQ:TCRT) Q1 2023 Earnings Call Transcriptfinance.yahoo.com - May 13 at 4:07 PM8-K: Alaunos Therapeutics, Inc.marketwatch.com - May 11 at 10:44 PMAlaunos Therapeutics, Inc.: Alaunos Therapeutics Reports First Quarter 2023 Financial Resultsfinanznachrichten.de - May 10 at 11:41 AMAlaunos Therapeutics GAAP EPS of -$0.04 in-linemsn.com - May 10 at 11:41 AMRecap: Alaunos Therapeutics Q1 Earningsmsn.com - May 10 at 11:41 AMAlaunos Therapeutics Reports First Quarter 2023 Financial Resultsfinance.yahoo.com - May 10 at 11:41 AMAlaunos Therapeutics to Report First Quarter 2023 Financial Results on May 10, 2023finance.yahoo.com - May 3 at 12:49 PMAlaunos Therapeutics Announces Poster Presentation at the American Society of Clinical Oncology (ASCO) 2023 Annual Meetingfinance.yahoo.com - April 26 at 2:37 PMThe past five years for Alaunos Therapeutics (NASDAQ:TCRT) investors has not been profitablefinance.yahoo.com - April 25 at 9:42 AMAlaunos Therapeutics Inc.barrons.com - April 2 at 6:26 PMAlaunos Therapeutics Appoints Dr. Robert J. Hofmeister to Board of Directorsfinance.yahoo.com - March 30 at 8:53 AMAlaunos Therapeutics to Participate in Upcoming Investor Conferences in Aprilfinance.yahoo.com - March 29 at 8:14 PMAlaunos Therapeutics, Inc. (NASDAQ:TCRT) to Post FY2023 Earnings of ($0.17) Per Share, Cantor Fitzgerald Forecastsmarketbeat.com - March 13 at 2:17 AMWhen Will Alaunos Therapeutics, Inc. (NASDAQ:TCRT) Turn A Profit?finance.yahoo.com - March 10 at 8:24 AMQ1 2023 EPS Estimates for Alaunos Therapeutics, Inc. Increased by HC Wainwright (NASDAQ:TCRT)marketbeat.com - March 10 at 5:50 AMAlaunos Therapeutics's Return On Capital Employed Overviewmsn.com - March 9 at 12:21 PMAlaunos Therapeutics, Inc. (NASDAQ:TCRT) Q4 2022 Earnings Call Transcriptfinance.yahoo.com - March 9 at 1:54 AMEarnings Outlook For Alaunos Therapeuticsmsn.com - March 6 at 7:18 PMAlaunos (TCRT) to Report Q4 Earnings: What's in the Cards?msn.com - March 3 at 3:55 PMAlaunos Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results on March 7, 2023finance.yahoo.com - March 1 at 10:55 AMErgoteles LLC Has $835,000 Holdings in Alaunos Therapeutics, Inc. (NASDAQ:TCRT)marketbeat.com - February 28 at 5:59 AMAlaunos Therapeutics, Inc.'s (NASDAQ:TCRT) largest shareholders are individual investors with 58% ownership, institutions own 22%finance.yahoo.com - February 17 at 10:14 AMIs Alaunos Therapeutics (TCRT) Outperforming Other Medical Stocks This Year?finance.yahoo.com - January 24 at 3:01 PMFY2022 EPS Estimates for Alaunos Therapeutics, Inc. Lifted by Analyst (NASDAQ:TCRT)marketbeat.com - January 13 at 6:16 AMAlaunos Therapeutics Highlights Strategic Priorities and Anticipated Portfolio Milestones for 2023finance.yahoo.com - January 9 at 1:33 PMAlaunos Therapeutics, Inc. (NASDAQ:TCRT) Q3 2022 Earnings Call Transcriptfinance.yahoo.com - December 29 at 9:14 AMTrade Alert: The Independent Director Of Alaunos Therapeutics, Inc. (NASDAQ:TCRT), Jaime Vieser, Has Just Spent US$813k Buying 117% More Sharesuk.news.yahoo.com - December 4 at 6:19 PMAlaunos Therapeutics, Inc. (NASDAQ:TCRT) Director Robert W. Postma Buys 750,000 Sharesmarketbeat.com - December 1 at 6:33 PMAlaunos Therapeutics Announces Pricing of Public Offering of Common Stockfinance.yahoo.com - November 29 at 12:41 PM Get Alaunos Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for TCRT and its competitors with MarketBeat's FREE daily newsletter. Email Address How to camouflage a factory of 53,000 workers (Ad)"If I Had To Pour Every Single Penny of My Retirement Into Just ONE STOCK..." The former Goldman Sachs VP – who called everything from Microsoft's 1,100% surge... to the death of the 60/40 portfolio – is now stepping forward with his most explicit message yet: "Make this ONE STOCK the cornerstone of your portfolio." Get the full story here. TCRT Media Mentions By Week TCRT Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TCRT News Sentiment▼0.000.43▲Average Medical News Sentiment TCRT News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TCRT Articles This Week▼00▲TCRT Articles Average Week Get Alaunos Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for TCRT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Galecto News BioVie News Aptorum Group News Flora Growth News NeuroSense Therapeutics News Addex Therapeutics News KALA BIO News FSD Pharma News RenovoRx News Vincerx Pharma News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TCRT) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyThe #1 Crypto for 2024InvestorPlaceEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsFed launches fourth dollar overhaulStansberry ResearchUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeGreat Crypto BullWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alaunos Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
